(AUDIO) The past year has been revolutionary for HIV-positive patients, both in medical care and in policy. And more is in store for the coming year, according to Dr. Michael Horberg of Kaiser Permanente. Listen as the immediate past president of the HIV Medicine Association briefly reviews events of 2013 and forecasts 2014.
(AUDIO) Now that guidelines mandate testing all adults for HIV status, what are the best ways to convey the results of this important but often sensitive test? Listen as the co-director of Emory University's Center for AIDS Research offers insights for effective communication on this topic.
What is the relationship between common illnesses and depression? And why is the relationship so strong? What can clinicians do now to manage both the medical illness and the depression?
(AUDIO) HIV-positive status is hardly a death sentence today, yet too many patients in the US do not complete the continuum of care from diagnosis to completion of antiretroviral therapy. AIDS specialist Katerina Chrstopoulos MD examines the barriers along the cascade of care, and suggests solutions.
Simvastatin 40 mg once daily can attenuate increases in cardiorespiratory fitness in response to exercise training.
(AUDIO) Antiviral drugs have reduced intrauterine transmission of HIV dramatically. But what are the effects on the pregnancy itself? Here an infectious diseases expert discusses the risks and the benefits.
Recurrent C difficile requires pulse vancomycin therapy; fecal microbiota transplant shows promise.
A key finding: a primary physician’s healthy lifestyle behaviors may be linked to his or her recommendations for hypertension prevention.
(AUDIO) The HIV Medicine Association has released a document that identifies the key characteristics of a medical provider qualified to manage the long-term care of patients infected with HIV. Here the chair of the organization describes the qualifications and tells why they are important.
The patient, an active 49-year-old man, had an HbA1c of 8.6 after diabetes was first diagnosed. It’s now 7.6 with metformin and lifestyle measures. Is the current A1c goal adequate, or should you treat more aggressively?